- Home
- APVO vs GITS Comparison
APVO vs GITS Comparison
Compare APVO & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- GITS
- Stock Information
- Founded
- APVO 2016
- GITS 2018
- Country
- APVO United States
- GITS South Korea
- Employees
- APVO N/A
- GITS N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- GITS
- Sector
- APVO Health Care
- GITS
- Exchange
- APVO Nasdaq
- GITS Nasdaq
- Market Cap
- APVO 5.4M
- GITS 4.8M
- IPO Year
- APVO N/A
- GITS N/A
- Fundamental
- Price
- APVO $1.38
- GITS $1.17
- Analyst Decision
- APVO Strong Buy
- GITS
- Analyst Count
- APVO 1
- GITS 0
- Target Price
- APVO $296.00
- GITS N/A
- AVG Volume (30 Days)
- APVO 1.2M
- GITS 76.9K
- Earning Date
- APVO 05-07-2025
- GITS 11-20-2024
- Dividend Yield
- APVO N/A
- GITS N/A
- EPS Growth
- APVO N/A
- GITS N/A
- EPS
- APVO N/A
- GITS N/A
- Revenue
- APVO N/A
- GITS N/A
- Revenue This Year
- APVO N/A
- GITS N/A
- Revenue Next Year
- APVO N/A
- GITS N/A
- P/E Ratio
- APVO N/A
- GITS N/A
- Revenue Growth
- APVO N/A
- GITS 85.47
- 52 Week Low
- APVO $0.94
- GITS $0.10
- 52 Week High
- APVO $180.19
- GITS $5.06
- Technical
- Relative Strength Index (RSI)
- APVO 31.11
- GITS N/A
- Support Level
- APVO $0.94
- GITS N/A
- Resistance Level
- APVO $2.64
- GITS N/A
- Average True Range (ATR)
- APVO 0.45
- GITS 0.00
- MACD
- APVO -0.07
- GITS 0.00
- Stochastic Oscillator
- APVO 16.42
- GITS 0.00
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.